Last Close
Mar 25  •  04:00PM ET
6.53
Dollar change
+0.14
Percentage change
2.19
%
Today, 4:15 PMLifeward closes strategic Oramed partnership, acquires POD oral delivery platform, draws $10M of up to $47M funding
Index- P/E- EPS (ttm)-18.51 Insider Own- Shs Outstand1.52M Perf Week-2.83%
Market Cap9.98M Forward P/E- EPS next Y-1.10 Insider Trans- Shs Float- Perf Month30.34%
Enterprise Value11.96M PEG- EPS next Q-1.18 Inst Own3.89% Short Float- Perf Quarter-19.98%
Income-19.91M P/S0.45 EPS this Y81.33% Inst Trans- Short Ratio7.51 Perf Half Y-20.39%
Sales22.03M P/B1.18 EPS next Y55.47% ROA-74.60% Short Interest0.21M Perf YTD-5.62%
Book/sh5.52 P/C4.14 EPS next 5Y65.68% ROE-146.12% 52W High23.04 -71.66% Perf Year-70.26%
Cash/sh1.58 P/FCF- EPS past 3/5Y13.33% 24.33% ROIC-208.15% 52W Low4.14 57.73% Perf 3Y-88.48%
Dividend Est.- EV/EBITDA- Sales past 3/5Y58.72% 38.06% Gross Margin38.25% Volatility7.79% 9.68% Perf 5Y-96.87%
Dividend TTM- EV/Sales0.54 EPS Y/Y TTM53.49% Oper. Margin-76.66% ATR (14)0.62 Perf 10Y-99.96%
Dividend Ex-Date- Quick Ratio0.84 Sales Y/Y TTM-14.14% Profit Margin-90.38% RSI (14)48.83 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.31 EPS Q/Q82.73% SMA20-1.21% Beta0.18 Target Price20.00
Payout- Debt/Eq0.52 Sales Q/Q-32.66% SMA50-4.69% Rel Volume0.60 Prev Close6.39
Employees81 LT Debt/Eq0.14 EarningsMar 18 BMO SMA200-17.55% Avg Volume27.72K Price6.53
IPOSep 12, 2014 Option/ShortNo / Yes EPS/Sales Surpr.-196.88% -35.42% Trades Volume16,571 Change2.19%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Initiated Laidlaw Buy $10
Apr-03-17Downgrade Barclays Equal Weight → Underweight $2.50 → $1.50
Dec-16-16Initiated Oppenheimer Outperform
Jul-15-16Initiated Piper Jaffray Overweight $10
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-08-15Reiterated Barclays Equal Weight $20 → $13
Oct-07-14Initiated Barclays Equal Weight $28
Today 04:10PM
Mar-18-26 03:02PM
08:17AM
08:00AM
Mar-17-26 09:24AM
08:00AM Loading…
Mar-13-26 08:00AM
Mar-11-26 08:00AM
Mar-10-26 04:15PM
Mar-02-26 08:00AM
Feb-25-26 08:00AM
Feb-20-26 08:00AM
Feb-17-26 08:00AM
Jan-13-26 08:00AM
Dec-19-25 04:05PM
Dec-17-25 08:00AM
08:00AM Loading…
Dec-03-25 08:00AM
Nov-17-25 08:00AM
Nov-14-25 04:01PM
08:11AM
08:00AM
Nov-13-25 07:31AM
Nov-10-25 07:00AM
Sep-09-25 08:45AM
08:30AM
Sep-08-25 08:30AM
Aug-14-25 09:10AM
08:06AM
08:00AM
Aug-13-25 08:00AM
Aug-12-25 06:00PM
05:30PM Loading…
Aug-07-25 05:30PM
05:25PM
Aug-06-25 10:50AM
Aug-05-25 06:20PM
Aug-04-25 08:30AM
Jul-07-25 11:00AM
Jun-26-25 04:15PM
09:15AM
Jun-25-25 09:10AM
Jun-24-25 04:05PM
May-20-25 08:00AM
May-19-25 08:30AM
06:00AM
May-16-25 03:08AM
May-15-25 09:15AM
08:00AM
May-08-25 08:30AM
May-07-25 04:30PM
Apr-29-25 08:30AM
Apr-24-25 08:30AM
Apr-16-25 07:13AM
Apr-15-25 08:15AM
Mar-23-25 08:40AM
Mar-13-25 09:15AM
Mar-08-25 02:03AM
Mar-07-25 08:00AM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-28-25 08:00AM
Feb-19-25 09:10AM
Feb-06-25 08:20AM
Feb-05-25 08:00AM
Feb-04-25 08:00AM
Jan-13-25 08:30AM
07:45AM
Jan-08-25 04:15PM
Jan-07-25 08:05AM
Dec-27-24 05:49PM
Nov-19-24 08:30AM
Nov-13-24 02:08AM
Nov-12-24 08:00AM
Nov-07-24 04:05PM
Nov-05-24 04:38PM
Nov-04-24 08:00AM
Oct-24-24 04:30PM
Sep-24-24 05:00PM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
Aug-08-24 04:15PM
Jul-02-24 04:30PM
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
May-07-24 04:30PM
May-02-24 10:01AM
Apr-26-24 10:19AM
Apr-23-24 09:55AM
Apr-19-24 08:30AM
Apr-12-24 08:30AM
Apr-01-24 04:30PM
Mar-24-24 03:54PM
Mar-22-24 08:30AM
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Hudson, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynch JeannineVP of Market Access & StrategySep 02 '25Sale0.641,5911,01846,067Sep 04 05:07 PM
Jasinski Lawrence JChief Executive OfficerMay 21 '25Sale1.261,9092,40598,728May 22 04:29 PM